Paper - WANFANG MED ONLINE

You Position: Home > Paper

Therapeutic effect and mechanism of probiotics on inflammatory bowel disease

( views:121, downloads:137 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 14

DOI:: 10.3969/j.issn.1009-3079.2007.14.010

Key Word:: 益生菌;炎症性肠病;肠道菌群

Abstract：炎症性肠病包括溃疡性结肠炎和克罗恩病.炎症性肠病患者肠道内存在菌群失调,若给患者补充正常细菌即益生菌,使肠道内菌群失调得到纠正,可使病情缓解.益生菌能改变肠道菌群比例、转化某些肠内物质、提高肠上皮的屏障功能、防止肠细菌易位以及通过调节细胞因子减轻炎症.本文对益生菌以上作用及机制作一综述.

Reference

[1]Ulf Helwig,Karen M Lammers,Fernando Rizzello,etc.Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-infiammatory cytokines in peripheral blood mononuclear cells[J].2006,(37).
[2]周俊,台卫平,张玫.益生菌对炎症性肠病的治疗作用[J].2006,(10).
[3]霍丽娟,赵和平.益生菌对溃疡性结肠炎大鼠结肠黏膜中IL-1和TNF-α表达的影响[J].2004,(4).
[4]崔海宏,陈村龙,王继德,等.双歧杆菌影响溃疡性结肠炎患者肠黏膜的研究[J].2003,(8).
[5]JONGDAE LEE,EYAL RAZ,DANIEL RACHMILEWITZ.Homeostatic Effects of TLR9 Signaling in Experimental Colitis[J].2006,1072(aug).
[6]Michael, Schultz,Antje, Timmer,Hans H, Herfarth,etc.Lactobacillus GG in inducing and maintaining remission of Crohn's disease.[J].2004,4.
[7]R, Fuller.Probiotics in man and animals.[J].1989,66.
[8]K L, Madsen,J S, Doyle,L D, Jewell,etc.Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.[J].1999,116.
[9]Regnier C,Lieske JC,De Simone C,etc.Use of a probiotic to decrease enteric hyperoxaluria.[J].2005,68(3).
[10]Kim N,Kweon MN,Kiyono H,etc.Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.[J].2007,123(1).
[11]Karen L. Madsen,David Malfair,Derek Gray,etc.Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora[J].1999,5(4).
[12]N, García-Urkia,A B, Asensio,I, Zubillaga Azpiroz,etc.[Beneficial effects of Bifidobacterium lactis in the prevention of bacterial translocation in experimental short bowel syndrome].[J].2002,15(4).
[13]Rosh JR,Goldin B,Evans J,etc.A Randomized, Double-blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease.[J].2005,11(9).
[14]Comalada M,Olivares M,Xaus J,etc.Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis.[J].2006,21(8).
[15]Tao Y,Drabik KA,Waypa TS,etc.Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells.[J].2006,290(4).
[16]Marco ML,Kleerebezem M,Pavan S.Towards understanding molecular modes of probiotic action[J].2006,17(2).
[17]Jacobsen M,Aabakken L,Aamodt G,etc.Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis.[J].2005,40(1).
[18]Palanki-MoorthyS S.Inhibitors of AP-1 and NF-kappa B mediated transcriptional activation: therapeutic potential in autoimmune diseases and structural diversity.[J].2002,9(2).
[19]TKu&#776,hbacher,S JOtt,etc.Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis[J].2006,55(6).
[20]Joshua R. Korzenik,Daniel K. Podolsky.Evolving knowledge and therapy of inflammatory bowel disease[J].2006,5(3).
[21]Pena AS,Karimi O,van Bodegraven AA.Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: A pilot study.[J].2005,41(7).